At a glance
ClinicalIndex Comparison RecordN/ACompleted· 298 enrolled
Drug / intervention
etafilcon A +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of the Performance of Investigational Contact Lenses in a Presbyopic Population
In Brief
A clinical study evaluating etafilcon A and lotrafilcon B for Presbyopia. Completed, enrolled 298 participants across 19 sites.
Detailed Summary
The objective of this study is to evaluate the performance of a novel multifocal lens system.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPresbyopia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2012
First PostedJan 2013
Primary CompletionFeb 2013
TodayJul 2026
First PostedJan 8, 2013
Enrollment StartNov 1, 2012
Primary CompletionFeb 1, 2013
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 13.5 years ago
Interventions
etafilcon Adevice
To be worn in a daily wear modality for a minimum of 6 hours per day.
lotrafilcon Bdevice
Lenses will be worn in a reuseable modality; cleaned and disinfected each night.